Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
    • Louder Than TB
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Developing New Regimens
    • Engaging Communities
  • Access
    • Our Commitment
    • Understanding the TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • 20 Years of Impact
  • Donate

Search form

Voices of TB

Videos from the Global Health Community

Featured Videos

Kenya Launches Child-Friendly TB Medicine

New Childhood TB Medicines Will Help Save Lives

Community Engagement

Dr. Eristavi's Story of #TBCourage

John Rovie's Story of #TBCourage

Dr. Gamkrelidze's Story of #TBCourage

Bongiswa's Story of #TBCourage

Nikoloz and Davit's Stories of #TBCourage

Dr. Janice Caoili's Story of #TBCourage

Spreading the Message

Empowering TB/HIV Patients in Kenya

TB Story on La 2 Noticias

History in the making

Engaging Communities in Nigeria

Without Community, Research is not Possible

  • Show more videos

Filter by Subject

Community Engagement (15)
CPTR (5)
Drug-resistance (23)
Market Access (6)
Patient Stories (21)
Pediatric TB (21)
Resource Mobilization (8)
TB-HIV (4)
TB Research (22)
TB Awareness (27)
TB Alliance (24)
TB Advocacy (23)
Join our mailing list and receive the latest news from TB Alliance.
Interests

Our Mission

TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

News Headlines

ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010
TB Alliance Announces First Patient Dosed with TBAJ-587 in Phase 1 Study

Contact Us

Press Inquiries

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings at the TB Alliance

Report a Concern

New York:

40 Wall Street, 24th floor, New York, NY 10005 • +1 212 227 7540

Pretoria:

Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328
© 2021 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern